ITC Orders Import Ban For Botox Rival In Trade Secrets Case
The U.S. International Trade Commission found Wednesday that Allergan's rivals should be barred from importing a low-cost version of its Botox treatment for 21 months because they misappropriated manufacturing trade secrets....To view the full article, register now.
Already a subscriber? Click here to view full article